Zobrazeno 1 - 10
of 563
pro vyhledávání: '"B. Streiff"'
Publikováno v:
Royal Society Open Science, Vol 10, Iss 10 (2023)
To understand mating-system evolution in self-compatible hermaphrodites, variation in selfing rates is highly relevant. Empirical studies are rarely designed to capture variation between individuals, instead often comparing species and populations. Y
Externí odkaz:
https://doaj.org/article/93deed41c2a84d36876e285c29a5fb50
Autor:
Elliott R. Haut, Oluwafemi P. Owodunni, Jiangxia Wang, Dauryne L. Shaffer, Deborah B. Hobson, Gayane Yenokyan, Peggy S. Kraus, Norma E. Farrow, Joseph K. Canner, Katherine L. Florecki, Kristen L.W. Webster, Christine G. Holzmueller, Jonathan K. Aboagye, Victor O. Popoola, Mujan Varasteh Kia, Peter J. Pronovost, Michael B. Streiff, Brandyn D. Lau
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 18 (2022)
Background Many hospitalized patients are not administered prescribed doses of pharmacologic venous thromboembolism prophylaxis. Methods and Results In this cluster‐randomized controlled trial, all adult non–intensive care units (10 medical, 6 su
Externí odkaz:
https://doaj.org/article/cf123f883da349169b6c0d5b54826a7b
Autor:
Kathleen M. Andersen, Corey S. Joseph, Hemalkumar B. Mehta, Michael B. Streiff, Joshua F. Betz, Robert C. Bollinger Jr, Arielle M. Fisher, Amita Gupta, Charles F. LeMaistre, Matthew L. Robinson, Yanxun Xu, Derek K. Ng, G. Caleb Alexander, Brian T. Garibaldi
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 5, Pp n/a-n/a (2022)
Abstract Background and Objectives Current clinical guidelines recommend thromboprophylaxis for adults hospitalized with coronavirus disease 2019 (COVID‐19), yet it is unknown whether higher doses of thromboprophylaxis offer benefits beyond standar
Externí odkaz:
https://doaj.org/article/84624ad9ddef4f7eb984ace062ba3ac1
Autor:
John-William Sidhom, Ingharan J. Siddarthan, Bo-Shiun Lai, Adam Luo, Bryan C. Hambley, Jennifer Bynum, Amy S. Duffield, Michael B. Streiff, Alison R. Moliterno, Philip Imus, Christian B. Gocke, Lukasz P. Gondek, Amy E. DeZern, Alexander S. Baras, Thomas Kickler, Mark J. Levis, Eugene Shenderov
Publikováno v:
npj Precision Oncology, Vol 5, Iss 1, Pp 1-8 (2021)
Abstract Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia (AML), classified by a translocation between chromosomes 15 and 17 [t(15;17)], that is considered a true oncologic emergency though appropriate therapy is considered c
Externí odkaz:
https://doaj.org/article/dd046aeb33da4cd3974afb7aa84c2bbd
Autor:
Alok A. Khorana, Nicole M. Kuderer, Keith McCrae, Dejan Milentijevic, Guillaume Germain, François Laliberté, Sean D. MacKnight, Patrick Lefebvre, Gary H. Lyman, Michael B. Streiff
Publikováno v:
Cancer Medicine, Vol 9, Iss 21, Pp 8062-8073 (2020)
Abstract Background The Khorana score (KS) clinical algorithm is used to predict VTE risk in cancer patients. The study objective was to evaluate VTE and survival rates among patients newly diagnosed with cancer and stratified by KS in a real‐world
Externí odkaz:
https://doaj.org/article/6e3e3acb042d48c0b6344f8f70c12a5f
Autor:
Jodi V. Mones, Michael B. Streiff, Alok A. Khorana, Gemma A. Bendheim, C. V. Damaraju, Peter Wildgoose, Paul Burton, Hanno Riess, Gerald A. Soff
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 5, Pp n/a-n/a (2021)
Abstract Background Prophylactic anticoagulation with rivaroxaban significantly reduced the risk of cancer‐associated thrombosis during the intervention period in the CASSINI trial. Direct oral anticoagulants may increase the risk of gastrointestin
Externí odkaz:
https://doaj.org/article/01708f1762434189891ef90745374b08
Autor:
Kathryn E. Dane, John P. Lindsley, Michael B. Streiff, Alison R. Moliterno, Mian K. Khalid, Satish Shanbhag
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 3, Iss 3, Pp 420-423 (2019)
Essentials Acquired hemophilia A is a rare bleeding disorder often accompanied by other comorbidities. We describe emicizumab use in acquired hemophilia A complicated by acute coronary syndrome. Emicizumab proved safe and effective in a patient with
Externí odkaz:
https://doaj.org/article/3cae2b0625fa42e6870960cb90e527de
Autor:
Oluwafemi P. Owodunni, Brandyn D. Lau, Jiangxia Wang, Dauryne L. Shaffer, Peggy S. Kraus, Christine G. Holzmueller, Jonathan K. Aboagye, Deborah B. Hobson, Mujan Varasteh Kia, Stephanie Armocida, Michael B. Streiff, Elliott R. Haut
Publikováno v:
Journal of Surgical Research. 280:151-162
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a02b4ff6c1301d34b630fd818276c17
https://doi.org/10.1016/j.jss.2022.07.015
https://doi.org/10.1016/j.jss.2022.07.015
Publikováno v:
TH Open, Vol 04, Iss 04, Pp e288-e299 (2020)
SARS-CoV-2 infection (COVID-19) results in local and systemic activation of inflammation and coagulation. In this review article, we will discuss the potential role of coagulation factor Xa (FXa) in the pathophysiology of COVID-19. FXa, a serine prot
Externí odkaz:
https://doaj.org/article/a5ec97cb2e734a279f71b9684dbab15a
Autor:
Alok A. Khorana, Mairéad G. McNamara, Ajay K. Kakkar, Michael B. Streiff, Hanno Riess, Ujjwala Vijapurkar, Simrati Kaul, Peter Wildgoose, Gerald A. Soff
Publikováno v:
TH Open, Vol 04, Iss 02, Pp e107-e112 (2020)
Introduction In the CASSINI study, rivaroxaban thromboprophylaxis significantly reduced primary venous thromboembolism (VTE) endpoints during the intervention period, but several thromboembolic events designated as secondary efficacy endpoints were n
Externí odkaz:
https://doaj.org/article/ee99dcca8b064679be805e3206169d47